File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer
  • Basic View
  • Metadata View
  • XML View
TitleA novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer
 
AuthorsHu, H3
Wang, YL3
Wang, GW3
Wong, YC2
Wang, XF3
Wang, Y1
Xu, KX3
 
KeywordsBladder Cancer
Epithelial-To-Mesenchymal Transition
Id-1
 
Issue Date2013
 
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/urolonco
 
CitationUrologic Oncology: Seminars And Original Investigations, 2013, v. 31 n. 7, p. 1242-1253 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.urolonc.2011.12.003
 
AbstractBackground and objective: Inhibitor of differentiation or DNA binding -1 (Id-1) has been shown to be increased in several types of advanced cancer, and to be associated with aggressive and metastatic abilities of cancer cells. Recently, more and more evidence indicates that epithelial-to-mesenchymal transition (EMT) is an important mechanism taking place during tumor invasion and metastasis, but the molecular pathways underlying EMT have not been clearly established. This study was to investigate the expression of Id-1 in bladder cancer and its association with EMT. Materials and methods: A total of 169 tissues, consisting of 147 primary bladder cancers and 22 adjacent normal tissues were included in this study. Id-1, E-cadherin, and β-catenin were examined immunohistochemically in paraffin sections. The pBabe-Id-1 expression retroviral vector and retroviral vectors containing an Id-1-specific small interfering RNA oligonucleotides (si-Id-1) were transfected into 2 bladder cancer cell lines respectively. Then, we used Western blotting and immunofluorescent staining to detect the cellular expression of epithelial markers and mesenchymal markers. The invasion and migration ability of bladder cancer cells were identified by type I collagen invasion assay and wound closure assay. Results: We demonstrated that increased Id-1 expression was associated with advanced tumor stage and grade. In addition, the increased Id-1 expression in bladder tumors was also correlated with decreased membranous E-cadherin and β-catenin expression. In vitro, studies showed that inactivation of the Id-1 gene conferred morphologic transition of bladder cancer cells from a fibroblastic to epithelial appearance, and overexpression of Id-1 could lead to acquisition of a fibroblastic spindle cell phenotype accompanied by loss of cell-to-cell contacts. By Western blotting and immunofluorescent staining, we showed that the expression level of Id-1 was correlated with the expression of mesenchymal markers but was inversely correlated with the expression of epithelial markers. Moreover, results of collagen invasion and wound closure assays showed ectopic Id-1 expression led to increased ability of invasion and migration. Conclusions: Our results suggest that Id-1 may play roles in tumor progression and EMT activation in bladder cancer. © 2011 Elsevier Inc. All rights reserved.
 
ISSN1078-1439
2013 Impact Factor: 3.363
 
DOIhttp://dx.doi.org/10.1016/j.urolonc.2011.12.003
 
ISI Accession Number IDWOS:000325664300041
 
DC FieldValue
dc.contributor.authorHu, H
 
dc.contributor.authorWang, YL
 
dc.contributor.authorWang, GW
 
dc.contributor.authorWong, YC
 
dc.contributor.authorWang, XF
 
dc.contributor.authorWang, Y
 
dc.contributor.authorXu, KX
 
dc.date.accessioned2012-06-26T05:58:26Z
 
dc.date.available2012-06-26T05:58:26Z
 
dc.date.issued2013
 
dc.description.abstractBackground and objective: Inhibitor of differentiation or DNA binding -1 (Id-1) has been shown to be increased in several types of advanced cancer, and to be associated with aggressive and metastatic abilities of cancer cells. Recently, more and more evidence indicates that epithelial-to-mesenchymal transition (EMT) is an important mechanism taking place during tumor invasion and metastasis, but the molecular pathways underlying EMT have not been clearly established. This study was to investigate the expression of Id-1 in bladder cancer and its association with EMT. Materials and methods: A total of 169 tissues, consisting of 147 primary bladder cancers and 22 adjacent normal tissues were included in this study. Id-1, E-cadherin, and β-catenin were examined immunohistochemically in paraffin sections. The pBabe-Id-1 expression retroviral vector and retroviral vectors containing an Id-1-specific small interfering RNA oligonucleotides (si-Id-1) were transfected into 2 bladder cancer cell lines respectively. Then, we used Western blotting and immunofluorescent staining to detect the cellular expression of epithelial markers and mesenchymal markers. The invasion and migration ability of bladder cancer cells were identified by type I collagen invasion assay and wound closure assay. Results: We demonstrated that increased Id-1 expression was associated with advanced tumor stage and grade. In addition, the increased Id-1 expression in bladder tumors was also correlated with decreased membranous E-cadherin and β-catenin expression. In vitro, studies showed that inactivation of the Id-1 gene conferred morphologic transition of bladder cancer cells from a fibroblastic to epithelial appearance, and overexpression of Id-1 could lead to acquisition of a fibroblastic spindle cell phenotype accompanied by loss of cell-to-cell contacts. By Western blotting and immunofluorescent staining, we showed that the expression level of Id-1 was correlated with the expression of mesenchymal markers but was inversely correlated with the expression of epithelial markers. Moreover, results of collagen invasion and wound closure assays showed ectopic Id-1 expression led to increased ability of invasion and migration. Conclusions: Our results suggest that Id-1 may play roles in tumor progression and EMT activation in bladder cancer. © 2011 Elsevier Inc. All rights reserved.
 
dc.description.naturelink_to_subscribed_fulltext
 
dc.identifier.citationUrologic Oncology: Seminars And Original Investigations, 2013, v. 31 n. 7, p. 1242-1253 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.urolonc.2011.12.003
 
dc.identifier.citeulike10235213
 
dc.identifier.doihttp://dx.doi.org/10.1016/j.urolonc.2011.12.003
 
dc.identifier.isiWOS:000325664300041
 
dc.identifier.issn1078-1439
2013 Impact Factor: 3.363
 
dc.identifier.pmid22226665
 
dc.identifier.scopuseid_2-s2.0-84884672985
 
dc.identifier.urihttp://hdl.handle.net/10722/149775
 
dc.languageeng
 
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/urolonco
 
dc.publisher.placeUnited States
 
dc.relation.ispartofUrologic Oncology: Seminars and Original Investigations
 
dc.subjectBladder Cancer
 
dc.subjectEpithelial-To-Mesenchymal Transition
 
dc.subjectId-1
 
dc.titleA novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Hu, H</contributor.author>
<contributor.author>Wang, YL</contributor.author>
<contributor.author>Wang, GW</contributor.author>
<contributor.author>Wong, YC</contributor.author>
<contributor.author>Wang, XF</contributor.author>
<contributor.author>Wang, Y</contributor.author>
<contributor.author>Xu, KX</contributor.author>
<date.accessioned>2012-06-26T05:58:26Z</date.accessioned>
<date.available>2012-06-26T05:58:26Z</date.available>
<date.issued>2013</date.issued>
<identifier.citation>Urologic Oncology: Seminars And Original Investigations, 2013, v. 31 n. 7, p. 1242-1253</identifier.citation>
<identifier.issn>1078-1439</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/149775</identifier.uri>
<description.abstract>Background and objective: Inhibitor of differentiation or DNA binding -1 (Id-1) has been shown to be increased in several types of advanced cancer, and to be associated with aggressive and metastatic abilities of cancer cells. Recently, more and more evidence indicates that epithelial-to-mesenchymal transition (EMT) is an important mechanism taking place during tumor invasion and metastasis, but the molecular pathways underlying EMT have not been clearly established. This study was to investigate the expression of Id-1 in bladder cancer and its association with EMT. Materials and methods: A total of 169 tissues, consisting of 147 primary bladder cancers and 22 adjacent normal tissues were included in this study. Id-1, E-cadherin, and &#946;-catenin were examined immunohistochemically in paraffin sections. The pBabe-Id-1 expression retroviral vector and retroviral vectors containing an Id-1-specific small interfering RNA oligonucleotides (si-Id-1) were transfected into 2 bladder cancer cell lines respectively. Then, we used Western blotting and immunofluorescent staining to detect the cellular expression of epithelial markers and mesenchymal markers. The invasion and migration ability of bladder cancer cells were identified by type I collagen invasion assay and wound closure assay. Results: We demonstrated that increased Id-1 expression was associated with advanced tumor stage and grade. In addition, the increased Id-1 expression in bladder tumors was also correlated with decreased membranous E-cadherin and &#946;-catenin expression. In vitro, studies showed that inactivation of the Id-1 gene conferred morphologic transition of bladder cancer cells from a fibroblastic to epithelial appearance, and overexpression of Id-1 could lead to acquisition of a fibroblastic spindle cell phenotype accompanied by loss of cell-to-cell contacts. By Western blotting and immunofluorescent staining, we showed that the expression level of Id-1 was correlated with the expression of mesenchymal markers but was inversely correlated with the expression of epithelial markers. Moreover, results of collagen invasion and wound closure assays showed ectopic Id-1 expression led to increased ability of invasion and migration. Conclusions: Our results suggest that Id-1 may play roles in tumor progression and EMT activation in bladder cancer. &#169; 2011 Elsevier Inc. All rights reserved.</description.abstract>
<language>eng</language>
<publisher>Elsevier Inc. The Journal&apos;s web site is located at http://www.elsevier.com/locate/urolonco</publisher>
<relation.ispartof>Urologic Oncology: Seminars and Original Investigations</relation.ispartof>
<subject>Bladder Cancer</subject>
<subject>Epithelial-To-Mesenchymal Transition</subject>
<subject>Id-1</subject>
<title>A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer</title>
<type>Article</type>
<description.nature>link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1016/j.urolonc.2011.12.003</identifier.doi>
<identifier.pmid>22226665</identifier.pmid>
<identifier.scopus>eid_2-s2.0-84884672985</identifier.scopus>
<identifier.isi>WOS:000325664300041</identifier.isi>
<publisher.place>United States</publisher.place>
<identifier.citeulike>10235213</identifier.citeulike>
</item>
Author Affiliations
  1. Peking University Health Science Center
  2. The University of Hong Kong
  3. Peking University